Skip to content

Exercise Therapy for Femoroacetabular Impingement Syndrome

The Effect of Patients' Characteristics on the Responsiveness to Exercise Therapy for the Management of Femoroacetabular Impingement Syndrome: a Multi-center, Single-group, Intervention Study

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04502043
Acronym
SWEaT
Enrollment
100
Registered
2020-08-06
Start date
2019-08-01
Completion date
2024-03-31
Last updated
2023-12-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Femoroacetabular Impingement Syndrome

Brief summary

The aim of the clinical trial is to investigate the characteristics of patients, who respond vs. not respond to exercise therapy for the nonsurgical management of femoroacetabular impingement syndrome (FAIS).

Detailed description

Patients with a diagnosis of FAIS will be recruited from 2 clinical centers and will receive exercise therapy (study intervention). Exercise therapy is a semi-standardized intervention and will last 12 weeks (3 months). Hip pain, function and quality of life will be assessed using a patient-reported questionnaire at baseline, 3, 6 and 12 months' follow-up. Hip joint contact pressure will be evaluated using motion analysis and modelling at baseline, 3 and 12 months' follow-up. Hip morphology will be evaluated using imaging at baseline and hip surgery rate will be evaluated at 6 and 12 months' follow-up.

Interventions

OTHERExercise therapy

* Education * Hip-specific strengthening exercises * Functional lower limb strengthening exercises * Core stability exercises * Postural balance exercises

Sponsors

Kantonsspital Winterthur KSW
CollaboratorOTHER
Schulthess Klinik
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 50 Years
Healthy volunteers
No

Inclusion criteria

* Age: 18 to 50 years; * Diagnosis of FAIS; * Availability of magnetic resonance arthrography and anteroposterior pelvic radiography of the involved hip; * Signed informed consent form.

Exclusion criteria

* Previous hip surgery; * Any surgery on the lower extremities in the last 6 months; * Hip dysplasia: lateral center edge angle \<25°; * Hip osteoarthritis: Tönnis grade \>1; * BMI: \>35 kg/m2; * Significant cardiopulmonary diseases.

Design outcomes

Primary

MeasureTime frameDescription
Change in hip pain, function and quality of lifeBaseline to 6 months' follow-upHip pain, function and quality of life will be assessed using the International Hip Outcome Tool - 33 Items

Secondary

MeasureTime frameDescription
Change in hip joint contact stressBaseline to 3 months' follow-upHip joint contact pressure will be assessed using modelling
Hip morphologyBaselineHip morphology will be assessed using imaging
Change in hip pain, function and quality of lifeBaseline to 12 months' follow-upHip pain, function and quality of life will be assessed using the International Hip Outcome Tool - 33 Items
Hip surgery rate6 months' follow-upNumber of patients who will decide to undergo hip surgery
Dropout3 months' follow-upNumber of patients who will not complete the non-surgical intervention protocol
Change in sport activity levelBaseline to 3 months' follow-upSport activity level will be assessed using the Hip Sports Activity Scale

Countries

Switzerland

Contacts

Primary ContactNicola C Casartelli, PhD
nicola.casartelli@kws.ch0443857971

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026